Exhibit 10.66
MASTER SEPARATION AND
DISTRIBUTION AGREEMENT
between
AGILENT
TECHNOLOGIES, INC.
and
VERIGY LTD.
Dated as of May 31,
2006
TABLE OF CONTENTS
|
|
Page
|
|
MASTER SEPARATION AND DISTRIBUTION
AGREEMENT
|
1
|
|
|
|
|
ARTICLE
I DEFINITIONS AND RULES OF
CONSTRUCTION
|
1
|
|
|
|
|
|
1.1.
|
Definitions
|
1
|
|
|
|
|
|
|
|
1.2.
|
Rules of Construction
|
1
|
|
|
|
|
|
|
ARTICLE
II PURCHASE PRICE AND ALLOCATION
|
2
|
|
|
|
|
|
2.1.
|
Payment of Purchase Price
|
2
|
|
|
|
|
|
|
|
2.2.
|
Allocation of Purchase
Price
|
2
|
|
|
|
|
|
|
|
2.3.
|
Receivables and Payables
|
2
|
|
|
|
|
|
|
ARTICLE
III DOCUMENTS AND ITEMS TO BE DELIVERED ON
THE SEPARATION DATE
|
3
|
|
|
|
|
|
3.1.
|
Documents to be Delivered by
Agilent
|
3
|
|
|
|
|
|
|
|
3.2.
|
Documents to Be Delivered by
Verigy
|
3
|
|
|
|
|
|
|
|
3.3.
|
Cash to be Transferred by
Agilent
|
3
|
|
|
|
|
|
|
ARTICLE
IV THE IPO AND ACTIONS PENDING THE
IPO
|
4
|
|
|
|
|
|
4.1.
|
Transactions Prior to the
IPO
|
4
|
|
|
|
|
|
|
|
4.2.
|
Proceeds of the IPO
|
4
|
|
|
|
|
|
|
|
4.3.
|
Conditions Precedent to Consummation
of the IPO
|
4
|
|
|
|
|
|
|
ARTICLE V THE
DISTRIBUTION
|
5
|
|
|
|
|
|
5.1.
|
The Distribution
|
5
|
|
|
|
|
|
|
|
5.2.
|
Actions Prior to the
Distribution
|
5
|
|
|
|
|
|
|
|
5.3.
|
Conditions to
Distribution
|
6
|
|
|
|
|
|
|
|
5.4.
|
Certain Stockholder
Matters
|
6
|
|
|
|
|
|
|
ARTICLE
VI FINANCIAL AND OTHER COVENANTS
|
7
|
|
|
|
|
|
6.1.
|
Financial and Other
Information
|
7
|
|
|
|
|
|
|
|
6.2.
|
Other Covenants
|
13
|
|
|
|
|
|
|
|
6.3.
|
Covenants Regarding the Incurrence
of Indebtedness
|
14
|
|
|
|
|
|
|
|
6.4.
|
Release of Lease
Guarantees
|
14
|
|
|
|
|
|
|
ARTICLE
VII ACCESS TO INFORMATION
|
14
|
|
|
|
|
|
7.1.
|
Restrictions on Disclosure of
Information
|
14
|
|
|
|
|
|
|
|
7.2.
|
Legally Required Disclosure of
Information
|
15
|
|
|
|
|
|
|
|
7.3.
|
Access to Information
|
15
|
|
|
|
|
|
|
|
7.4.
|
Record Retention
|
16
|
i
|
|
7.5.
|
Production of Witnesses
|
16
|
|
|
|
|
|
|
|
7.6.
|
Reimbursement
|
16
|
|
|
|
|
|
|
|
7.7.
|
Other Agreements Regarding Access to
Information
|
16
|
|
|
|
|
|
|
|
7.8.
|
Acquisition of Verigy by another
Person
|
17
|
|
|
|
|
|
|
ARTICLE
VIII ADDITIONAL COVENANTS AND OTHER
MATTERS
|
17
|
|
|
|
|
|
8.1.
|
Performance
|
17
|
|
|
|
|
|
|
|
8.2.
|
Existing Litigation
Matters
|
17
|
|
|
|
|
|
|
|
8.3.
|
Insurance Matters
|
17
|
|
|
|
|
|
|
|
8.4.
|
Export Control Compliance
|
19
|
|
|
|
|
|
|
|
8.5.
|
Conduct of Business between
Separation Date and the IPO Settlement Date
|
19
|
|
|
|
|
|
|
|
8.6.
|
Conduct of Business between IPO
Settlement Date and Distribution Date
|
19
|
|
|
|
|
|
|
ARTICLE
IX INDEMNIFICATION
|
19
|
|
|
|
|
|
9.1.
|
Indemnification by Verigy
Group
|
19
|
|
|
|
|
|
|
|
9.2.
|
Indemnification by Agilent
Group
|
20
|
|
|
|
|
|
|
|
9.3.
|
Claim Procedure
|
20
|
|
|
|
|
|
|
|
9.4.
|
Survival; Limitations
|
21
|
|
|
|
|
|
|
ARTICLE
X MISCELLANEOUS
|
22
|
|
|
|
|
|
10.1.
|
Governing Law
|
22
|
|
|
|
|
|
|
|
10.2.
|
Jurisdiction
|
23
|
|
|
|
|
|
|
|
10.3.
|
Dispute Resolution
|
23
|
|
|
|
|
|
|
|
10.4.
|
Notices
|
23
|
|
|
|
|
|
|
|
10.5.
|
Binding Effect and
Assignment
|
24
|
|
|
|
|
|
|
|
10.6.
|
Severability
|
24
|
|
|
|
|
|
|
|
10.7.
|
Entire Agreement
|
24
|
|
|
|
|
|
|
|
10.8.
|
Counterparts
|
24
|
|
|
|
|
|
|
|
10.9.
|
Expenses
|
25
|
|
|
|
|
|
|
|
10.10.
|
Amendment
|
25
|
|
|
|
|
|
|
|
10.11.
|
Waiver
|
25
|
|
|
|
|
|
|
|
10.12.
|
Authority
|
25
|
|
|
|
|
|
|
|
10.13.
|
Termination
|
25
|
ii
MASTER SEPARATION AND
DISTRIBUTION AGREEMENT
THIS MASTER SEPARATION AND
DISTRIBUTION AGREEMENT (the “ Agreement ”) is
dated as of May 31, 2006, by and between Agilent
Technologies, Inc., a Delaware corporation (“
Agilent ”), and Verigy Ltd., a company organized
under the laws of Singapore (together with its successors and
assigns, “ Verigy ”) (each, a “
Party ” and, collectively, the “ Parties
”).
W I T N E S S E T H:
WHEREAS , Agilent has determined that it would be
appropriate, desirable and in the best interests of Agilent and
Agilent’s stockholders to separate the Business from
Agilent;
WHEREAS , it is the intent of the Parties, in accordance
with the General Assignment and Assumption Agreement to be entered
into between the Parties (the “ General Assignment and
Assumption Agreement ”) and the other agreements and
instruments provided for in this Agreement, that Agilent and its
Subsidiaries convey to Verigy and its Subsidiaries substantially
all of the business and assets of the Business and that Verigy and
its Subsidiaries assume certain of the liabilities of Agilent and
its Subsidiaries related to the Business (the “
Transfer ”);
WHEREAS, the Parties understand that
Agilent has entered into certain asset purchase agreements,
inventory purchase agreements and other agreements ancillary
thereto (collectively, the “ Flextronics Transfer
Agreements ”), with one or more subsidiaries or
affiliates of Flextronics International Ltd. (“
Flextronics ”), which agreements contemplate the
transfer of certain assets and employees relating to the Business
from Agilent to Flextronics on or about the Separation
Date;
WHEREAS , Verigy intends to offer and sell for its own
account a limited number of Verigy Ordinary Shares pursuant to an
initial public offering of such shares (the “ IPO
”), and in furtherance thereof, Verigy has previously filed
the IPO Registration Statement with the SEC which has not yet
become effective;
WHEREAS , Agilent intends, after the IPO, to distribute
to holders of shares of Agilent Common Stock the outstanding Verigy
Ordinary Shares then owned by Agilent (the “
Distribution ”); and
WHEREAS , the parties intend in this Agreement and the
Transaction Documents to set forth the principal arrangements
between them regarding the Transfer, the IPO and the
Distribution:
NOW, THEREFORE
, in consideration of the foregoing
and the mutual covenants and agreements set forth below, and other
good and valuable consideration, the receipt and adequacy of which
is hereby acknowledged, the parties hereby agree as
follows:
ARTICLE I
DEFINITIONS AND RULES OF
CONSTRUCTION
1.1.
Definitions .
Unless otherwise provided herein,
capitalized terms used in this Agreement have the meanings ascribed
to them by definition in this Agreement or in Annex A.
1.2.
Rules of Construction .
(a) This Agreement
shall be construed without regard to any presumption or rule
requiring construction or interpretation against the Party drafting
or causing any instrument to be drafted.
(b) The words
“hereof, “herein” and “hereunder” and
words of similar import when used in this Agreement will refer to
this Agreement as a whole (including any annexes, exhibits and
schedules to this Agreement) and not to any particular provision of
this Agreement, and section and subsection
1
references are to this Agreement unless
otherwise specified. The words “include”,
“including”, or “includes” when used herein
shall be deemed in each case to be followed by the words
“without limitation” or words having similar import.
The headings and table of contents in this Agreement are included
for convenience of reference only and will not limit or otherwise
affect the meaning or interpretation of this Agreement. The
meanings given to terms defined herein will be equally applicable
to both the singular and plural forms of such terms.
ARTICLE II
PURCHASE PRICE AND
ALLOCATION
2.1
Payment of Purchase Price
.
The total consideration in respect
of the Transfer contemplated by this Agreement and the General
Assignment and Assumption Agreement shall consist of (i) a
cash payment equal to $535 million (the “ Purchase
Price ”) and (ii) the assumption of liabilities
specified in the General Assignment and Assumption Agreement. The
Purchase Price shall be payable by Verigy to Agilent on the
Separation Date in United States dollars (or in other currencies in
certain foreign jurisdictions) in immediately available federal
funds to such bank account or accounts as shall be designated in
writing by Agilent no later than the second Business Day prior to
the Separation Date or as otherwise set forth in the applicable
Ancillary Agreement.
2.2
Allocation of Purchase Price
.
(a) The Agilent Tax
Group and the Verigy Tax Group agree to allocate the total
consideration described in Section 2.1 (and all other
capitalizable costs) among the Transferred Assets, the Transferred
Intellectual Property Rights for all purposes (including financial
accounting and Tax purposes (except as otherwise required by
generally accepted accounting principles)) in accordance with an
allocation schedule (the “ Allocation Schedule
”) prepared jointly by the Agilent Tax Group and the Verigy
Tax Group in accordance with Section 1060 of the Code and the
Treasury Regulations promulgated thereunder. The Agilent Tax Group
and the Verigy Tax Group agree to cooperate with each other in the
preparation of, and to negotiate in good faith to resolve any
dispute with respect to, the Allocation Schedule.
(b) The Verigy Tax
Group and the Agilent Tax Group shall be bound by such Allocation
Schedule and shall file, according to Section 1060 of the
Code, all returns (including, without limitation, filing
Form 8594) and reports with respect to the transactions
contemplated by this Agreement (including, without limitation, all
federal, state and local Tax returns) on the basis of such
allocation. In addition, the Verigy Tax Group and the Agilent Tax
Group shall act in accordance with the Allocation Schedule in the
course of any Tax audit, Tax review or Tax litigation relating
thereto, and take no position and cause their affiliates to take no
position inconsistent with the Allocation Schedule for income Tax
purposes, including United States federal and state income Tax and
foreign income Tax, unless otherwise required pursuant to a
“determination” within the meaning of
Section 1313(a) of the Code.
2.3.
Receivables and Payables
.
Agilent shall pay to Verigy any
payments received by Agilent or any of its Subsidiaries after the
Separation Date in respect of accounts receivable of Verigy arising
on, prior to or after the Separation Date within five
(5) Business Days of Agilent’s receipt thereof. To the
extent that any accounts payable are included in the Assumed
Liabilities, Agilent will pay such accounts payable on behalf of
Verigy after the Separation Date, provided that any such
payments will be made by Agilent only at such times and in such
amounts as are directed by Verigy. Verigy will reimburse Agilent
for any such amounts paid by Agilent at Verigy’s direction
within five (5) Business Days of such payments.
2
ARTICLE III
DOCUMENTS AND ITEMS TO BE
DELIVERED ON THE SEPARATION DATE
3.1.
Documents to be Delivered by
Agilent. On or prior to the Separation
Date, or such later date as agreed to by the Parties, Agilent will
deliver, or will cause its appropriate Subsidiaries to deliver, to
Verigy all of the following items and agreements (collectively,
together with all agreements and documents contemplated by such
agreements, the “ Transaction Documents
”):
(a) a duly executed
General Assignment and Assumption Agreement substantially in the
form attached hereto as Exhibit A ;
(b) Certificates
representing the stock and/or investments in the Subsidiaries and
other holdings of Agilent set forth on Schedule 1 with
duly executed stock powers in the form proper for
transfer;
(c) a duly executed
Intellectual Property Matters Agreement substantially in the form
attached hereto as Exhibit B-1 and a duly executed
Manufacturing Trademark License Agreement substantially in the form
attached hereto as Exhibit B-2 ;
(d) a duly executed
Employee Matters Agreement substantially in the form attached
hereto as Exhibit C ;
(e) a duly executed
Tax Sharing Agreement substantially in the form attached hereto as
Exhibit D ;
(f) a duly
executed Transition Services Agreement substantially in the form
attached hereto as Exhibit E ;
(g) a duly executed
loan agreement (the “ Loan Facility Agreement ”)
substantially in form attached hereto as Exhibit F
.
(h) a duly executed
Share Subscription Agreement substantially in the form attached
hereto as Exhibit G ;
(i) resignations of each
person who is an officer of Verigy or an officer or director of any
of its Subsidiaries, immediately prior to the Separation Date, and
who will be employees of Agilent from and after the Separation
Date; and
(j) such
other agreements, documents or instruments as the Parties may agree
are necessary or desirable in order to achieve the purposes
hereof.
3.2
Documents to Be Delivered by Verigy
. As of the Separation Date, Verigy will or
will cause its appropriate Subsidiaries to deliver to Agilent all
of the following:
(a) in each case
where Verigy is a party to any agreement or instrument referred to
in Section 3.1, a duly executed counterpart of such agreement
or instrument; and
(b) resignations of
each person who is an officer or director of Agilent or its
Subsidiaries (other than Verigy or any of its Subsidiaries)
immediately prior to the Separation Date, and who will be employees
of Verigy from and after the Separation Date.
3.3 Cash
to be Contributed by Agilent. On or
prior to the Separation Date, or such later date as may be mutually
agreed to by the Parties, Agilent shall make a capital contribution
to Verigy in the amount of $535 million pursuant to the terms
of the Share Subscription Agreement referenced in
Section 3.1(h).
3
ARTICLE IV
THE IPO AND ACTIONS PENDING THE
IPO
4.1
Transactions Prior to the IPO
. Subject to the conditions hereof, Agilent
and Verigy will use their commercially reasonable efforts to
consummate the IPO, including, without limitation, by taking the
actions specified in this Section 4.1.
(a) Verigy will
file such amendments or supplements to the IPO Registration
Statement as may be necessary in order to cause the IPO
Registration Statement to become and remain effective as required
by applicable law or by the Underwriters, including, without
limitation, filing such amendments and supplements thereto as may
be required by the Underwriting Agreement, the SEC or applicable
securities laws. Agilent and Verigy will also cooperate in
preparing, filing with the SEC and causing to become effective a
registration statement registering the Verigy Ordinary Shares under
the Exchange Act, and any registration statements or amendments
thereto which are required to reflect the establishment of, or
amendments to, any employee benefit and other plans necessary or
appropriate in connection with the IPO, the Distribution or the
other transactions contemplated by this Agreement and the
Transaction Documents.
(b) Verigy will
enter into the Underwriting Agreement, in form and substance
reasonably satisfactory to Verigy, and Verigy will comply with its
obligations thereunder.
(c) Verigy will use
its commercially reasonable efforts to take all such action as may
be necessary or appropriate under applicable state securities and
blue sky laws of the United States (and any comparable laws under
any foreign jurisdictions) in connection with the IPO.
(d) Verigy will
prepare, file and use commercially reasonable efforts to seek to
make effective, an application for listing of the Verigy Ordinary
Shares to be issued in the IPO on the Nasdaq National Market,
subject to official notice of issuance.
(e) Verigy and
Agilent will participate in the preparation of materials and
presentations that Agilent, Verigy and the Underwriters may deem
necessary or desirable.
(f) Verigy
will cooperate in all respects with Agilent in connection with the
pricing and timing of the Verigy Ordinary Shares to be issued in
the IPO and will, at Agilent’s direction, promptly take any
and all actions necessary or desirable to consummate the IPO as
contemplated by the IPO Registration Statement and the Underwriting
Agreement.
4.2
Proceeds of the IPO
. Except as may be otherwise agreed by the
parties, the IPO will be a primary offering of Verigy Ordinary
Shares, and the net proceeds of the IPO will be used as described
in the IPO Registration Statement in the section entitled
“Use of Proceeds”.
4.3
Conditions Precedent to Consummation of
the IPO . The obligations of the Parties
to consummate the IPO will be subject to such conditions as Agilent
will determine in its sole and absolute discretion, which
conditions will be for the sole benefit of Agilent, may be waived
by Agilent in its sole and absolute discretion, and any
determination by Agilent regarding the satisfaction or waiver of
any of such conditions will be conclusive. Such conditions will
include, without limitation, the following:
(a) The IPO
Registration Statement will have been declared effective by the
SEC, and there will be no stop order in effect with respect thereto
and no proceeding for that purpose will have been instituted by the
SEC;
(b) The actions and
filings with regard to state securities and blue sky laws of the
United States (and any comparable laws under any foreign
jurisdictions) referred to in Section 4.1 will have been taken
and, where applicable, have become effective or been
accepted;
4
(c) The Verigy
Ordinary Shares to be issued in the IPO will have been accepted for
listing on the Nasdaq National Market, on official notice of
issuance;
(d) Verigy will
have entered into the Underwriting Agreement and all conditions to
the obligations of Verigy and the Underwriters thereunder will have
been satisfied or waived;
(e) Agilent will be
satisfied in its sole and absolute discretion that (i) it will
possess Tax Control of Verigy immediately following the
consummation of the IPO, (ii) to the extent applicable as of
the time the IPO is consummated, the other conditions for a
distribution qualifying under Section 355 of the Code will be
satisfied or can reasonably be anticipated to be satisfied, and
(iii) there will be no event or condition that may cause any
of such conditions not to be satisfied as of the time of the
Distribution or thereafter;
(f) No order,
injunction or decree issued by any court or agency of competent
jurisdiction or other legal restraint or prohibition preventing the
consummation of the IPO or any of the other transactions
contemplated by this Agreement or any Transaction Document will be
in effect;
(g) Agilent will
have determined that the terms of the IPO, including the timing and
pricing thereof, and other material matters in connection
therewith, are acceptable to Agilent; and
(h) This Agreement
will not have been terminated.
ARTICLE V
THE DISTRIBUTION
5.1 The
Distribution . Agilent will, in its sole
and absolute discretion, determine the date of the consummation of
the Distribution and all terms of the Distribution, including
without limitation, the form, structure and terms of any
transaction(s) and/or offering(s) to effect the Distribution and
the timing of and conditions to the consummation of the
Distribution. In addition, Agilent may, at any time and from time
to time until the completion of the Distribution, modify or change
the terms of the Distribution, including, without limitation, by
accelerating or delaying the timing of the consummation of all or
part of the Distribution. Verigy will cooperate with Agilent in all
respects to accomplish the Distribution and will, at
Agilent’s direction, promptly take any and all reasonable
actions necessary or desirable to effect the Distribution,
including, without limitation, to the extent necessary, the
registration under the Securities Act and the Exchange Act of the
Verigy Ordinary Shares on an appropriate registration form or forms
to be designated by Agilent. Agilent will select any investment
banker(s) and manager(s) in connection with the Distribution, as
well as any financial printer, solicitation and/or exchange agent
and financial, legal, accounting and other advisors for Agilent,
provided, however, that nothing in this Agreement will prohibit
Verigy from engaging (at its own expense) its own financial, legal,
accounting and other advisors in connection with the
Distribution.
5.2
Actions Prior to the Distribution
. In connection with the Distribution, the
parties will take the actions set forth in this
Section 5.2.
(a) Agilent and
Verigy will prepare and mail, prior to any Distribution Date, to
the holders of Agilent Common Stock, such information concerning
Verigy and the Distribution and such other matters as Agilent
reasonably determines and as may be required by law. Agilent and
Verigy will prepare, and Verigy will, to the extent required by
applicable law, file with the SEC any such documentation that
Agilent determines is necessary or desirable to effect the
Distribution, and Agilent and Verigy will each use its commercially
reasonable efforts to obtain all necessary approvals from the SEC
with respect thereto as soon as practicable.
5
(b) Verigy will use
its commercially reasonable efforts to take all such action as may
be necessary or desirable under applicable state securities and
blue sky laws of the United States (and any comparable laws under
any foreign jurisdictions) in connection with the
Distribution.
(c) Verigy will
prepare, file and use commercially reasonable efforts to seek to
make effective, an application for listing of the Verigy Ordinary
Shares to be distributed in the Distribution on the Nasdaq National
Market, subject to official notice of issuance.
(d) Verigy will
take all reasonable steps necessary or desirable to cause the
conditions set forth in Section 5.3 to be satisfied and to
effect the Distribution.
5.3
Conditions to Distribution
. The consummation of the Distribution will
be subject to the satisfaction, or waiver by Agilent in its sole
and absolute discretion, of the conditions set forth in this
Section 5.3. Any determination by Agilent regarding the
satisfaction or waiver of any of such conditions will be
conclusive. For the avoidance of doubt, in the event that Agilent
determines not to consummate the Distribution because one or more
of such conditions is not satisfied or for any other reason, such
determination by Agilent will not affect the effectiveness of the
Transfer or the IPO.
(a) The receipt by
Agilent, in form and substance satisfactory to it, of an opinion
from its Tax Advisor that the Distribution should qualify as a
distribution under Section 355 of the Code, subject to
Section 367 of the Code, and such other matters as Agilent may
determine to be necessary or advisable in its sole and absolute
discretion.
(b) The receipt of
any governmental approvals and material consents necessary to
consummate the Distribution, which approvals and consents will be
in full force and effect.
(c) No order,
injunction, decree or regulation issued by any court or agency of
competent jurisdiction or other legal restraint or prohibition
preventing the consummation of the Distribution will be in effect
and no other event outside the control of Agilent will have
occurred or failed to occur that prevents the consummation of the
Distribution.
(d) The actions and
filings necessary or appropriate under applicable securities laws
in connection with the Distribution will have been taken or made,
and, where applicable, have become effective or been
accepted.
(e) The Verigy
Ordinary Shares to be distributed in the Distribution will have
been accepted for listing on the Nasdaq National Market, subject to
official notice of issuance.
(f) The
receipt by Agilent, in form and substance satisfactory to it, of
(i) an opinion from Delaware counsel, selected by Agilent in
its sole and absolute discretion, regarding the appropriateness of
the determination by the Agilent Board of Directors that Agilent
has sufficient surplus under Delaware law to permit the
Distribution and (ii) appropriate certificates from Verigy
with respect to factual matters required by the advisors to render
the opinions referenced in (i).
5.4
Certain Stockholder Matters
.
(a) Subject to
Section 5.3 hereof, on or prior to the Distribution Date,
Agilent will deliver to a distribution agent to be appointed by
Agilent (the “ Distribution Agent ”) for the
benefit of holders of record of Agilent Common Stock on the Record
Date, a single share certificate, endorsed by Agilent in blank,
representing all of the outstanding Verigy Ordinary Shares then
owned by Agilent, and Agilent will instruct the Distribution Agent
to deliver to the Verigy Transfer Agent true, correct and complete
copies of the stock and transfer records reflecting the holders of
Agilent Common Stock entitled to receive Verigy Ordinary Shares in
connection with the Distribution. Agilent will cause its transfer
agent to instruct the Distribution Agent to distribute on the
Distribution Date or as soon as reasonably practicable thereafter
the appropriate number of Verigy Ordinary Shares to each such
holder or designated transferee(s) of such holder. Agilent will
cooperate, and will instruct the Distribution Agent
6
to cooperate, with Verigy and the Verigy
Transfer Agent, and Verigy will cooperate, and will instruct the
Verigy Transfer Agent to cooperate, with Agilent and the
Distribution Agent, in connection with all aspects of the
Distribution and all other matters relating to the issuance and
delivery of certificates representing, or other evidence of
ownership of, the Verigy Ordinary Shares to be distributed to the
holders of Agilent Common Stock in connection with the
Distribution.
(b) Subject to
Section 5.4(d), each holder of Agilent Common Stock on the
Record Date (or such holder’s designated transferee(s)) will
be entitled to receive in the Distribution a number of Verigy
Ordinary Shares equal to the number of shares of Agilent Common
Stock held by such holder on the Record Date, multiplied by a
fraction, (i) the numerator of which is the number of Verigy
Ordinary Shares beneficially owned by Agilent or any other member
of the Agilent Group on the Record Date, and (ii) the
denominator of which is the number of shares of Agilent Common
Stock outstanding on the Record Date.
(c) Until such
Verigy Ordinary Shares are duly transferred in accordance with
applicable law, from and after the Distribution Date, Verigy will
regard the Persons entitled to receive such Verigy Ordinary Shares
as record holders of Verigy Ordinary Shares in accordance with the
terms of the Distribution without requiring any action on the part
of such Persons. Verigy agrees that, subject to any transfers of
such stock, (i) each such holder will be entitled to receive
all dividends payable on, and exercise voting rights and all other
rights and privileges with respect to, the Verigy Ordinary Shares
then held by such holder, and (ii) each such holder will be
entitled, without any action on the part of such holder, to receive
one or more certificates representing, or other evidence of
ownership of, the Verigy Ordinary Shares then held by such
holder.
(d) Notwithstanding
anything to the contrary in this Section 5.4, in the event
that the Distribution is not made in the form of a pro rata
distribution of Verigy Ordinary Shares to holders of Agilent Common
Stock, the above provisions of this Section 5.4 will not apply
to the Distribution.
ARTICLE VI
FINANCIAL AND OTHER
COVENANTS
6.1
Financial and Other Information
.
(a)
Financial Information
. Verigy agrees that, for so long as Agilent
is required to consolidate the results of operations and financial
position of Verigy and any other members of the Verigy Group or to
account for its investment in Verigy under the equity method of
accounting (determined in accordance with generally accepted
accounting principles consistently applied and consistent with SEC
reporting requirements):
(i)
Disclosure of Financial Controls
. Verigy will, and will cause each other
member of the Verigy Group to, maintain, as of and after the
Separation Date, disclosure controls and procedures and internal
control over financial reporting as defined in Exchange Act
Rule 13a-15 promulgated under the Exchange Act; Verigy will
cause each of its principal executive officer and its principal
financial officer to sign and deliver certifications to
Verigy’s periodic reports and will include the certifications
in Verigy’s periodic reports, as and when required pursuant
to Exchange Act Rule 13a-14 and Item 601 of
Regulation S-K; Verigy will cause its management to evaluate
Verigy’s disclosure controls and procedures and internal
control over financial reporting (including any change in internal
control over financial reporting) as and when required pursuant to
Exchange Act Rule 13a-15; Verigy will disclose in its periodic
reports filed with the SEC information concerning Verigy
management’s responsibilities for and evaluation of
Verigy’s disclosure controls and procedures and internal
control over financial reporting (including, without limitation,
the annual management report and attestation report of
Verigy’s independent auditors relating to internal control
over financial reporting) as and when required under Items 307
and
7
308 of Regulation S-K and other
applicable SEC rules; and, without limiting the general application
of the foregoing, Verigy will, and will cause each other member of
the Verigy Group to, maintain as of and after the Separation Date
internal systems and procedures that will provide reasonable
assurance that (A) the Financial Statements are reliable and
timely prepared in accordance with GAAP and applicable law,
(B) all transactions of members of the Verigy Group are
recorded as necessary to permit the preparation of the Financial
Statements, (C) the receipts and expenditures of members of
the Verigy Group are authorized at the appropriate level within
Verigy, and (D) unauthorized use or disposition of the assets
of any member of the Verigy Group that could have material effect
on the Financial Statements is prevented or detected in a timely
manner (it being understood that the foregoing shall not require
Verigy to comply with Section 404 of the Sarbanes-Oxley Act of
2002 as of an earlier date than it would otherwise be required to
so comply under applicable law).
(ii)
Fiscal Year
. Verigy will, and will cause each member of
the Verigy Group to, maintain a fiscal year that commences and ends
on the same calendar days as Agilent’s fiscal year commences
and ends, and to maintain monthly accounting periods that commence
and end on the same calendar days as Agilent’s monthly
accounting periods commence and end.
(iii)
Monthly Financial Reports
. For each monthly accounting period after
the Separation Date, Verigy shall use its reasonable best efforts
to comply with Agilent’s standard financial reporting
timeline for the provision of consolidated income statements,
balance sheets and cash flows of Verigy and each Verigy Affiliate
that is consolidated with Verigy for such period, in such format
and detail as Agilent may request; provided that in any case Verigy
shall provide such financial information not later than eight
(8) Business Days following the end of each monthly accounting
period of Verigy.
(iv)
Quarterly Financial Statements
. As soon as practicable and within
Agilent’s standard financial reporting timeline, and in any
event no later than ten (10) Business Days prior to the date
on which Agilent has notified Verigy that Agilent intends to file
its Form 10-Q or other document containing quarterly financial
statements with the SEC, Verigy will deliver to Agilent drafts of
(A) the consolidated financial statements of the Verigy Group
(and notes thereto) for such periods and for the period from the
beginning of the current fiscal year to the end of such quarter,
setting forth in each case in comparative form for each such fiscal
quarter of Verigy the consolidated figures (and notes thereto) for
the corresponding quarter and periods of the previous fiscal year
and all in reasonable detail and prepared in accordance with
Article 10 of Regulation S-X and GAAP, and (B) a
discussion and analysis by management of the Verigy Group’s
financial condition and results of operations for such fiscal
period, including, without limitation, an explanation of any
material period-to-period change and any off-balance sheet
transactions, all in reasonable detail and prepared in accordance
with Item 303(b) of Regulation S-K; provided ,
however , that the foregoing requirement shall not apply to
the first quarterly reporting period of Verigy following the IPO if
Verigy is not required by the Exchange Act to file its
Form 10-Q for such period within forty-five (45) days of
the end of such quarter. The information set forth in (A) and
(B) above is referred to in this Agreement as the “
Quarterly Financial Statements .” No later than three
(3) Business Days prior to the date on which Agilent has
notified Verigy that Agilent intends to file the Agilent quarterly
financial statements with the SEC, Verigy will use its commercially
reasonable efforts to deliver to Agilent the final form of the
Verigy Quarterly Financial Statements and certifications thereof by
the principal executive and financial officers of Verigy in
substantially the forms required under SEC rules for periodic
reports and in form and substance satisfactory to Agilent;
provided , however , that Verigy may continue to
revise such Quarterly Financial Statements prior to the filing
thereof in order to make corrections and changes which corrections
and changes will be delivered by Verigy to Agilent as soon as
practicable, and in any event within eight (8) hours
thereafter; provided , further , that Agilent’s
and
8
Verigy’s financial
Representatives will actively consult with each other regarding any
changes which Verigy may consider making to its Quarterly Financial
Statements and related disclosures during the two (2) Business
Days immediately prior to any anticipated filing with the SEC, to
the extent that such changes would have an effect upon
Agilent’s financial statements or related disclosures. In
addition to the foregoing, no Quarterly Financial Statement or any
other document which refers, or contains information not previously
publicly disclosed with respect to the ownership of Verigy by
Agilent, the separation of Verigy from Agilent or the Distribution
will be filed with the SEC or otherwise made public by any Verigy
Group member without the prior written consent of Agilent, which
will not be unreasonably withheld. Agilent and Verigy will
cooperate with each other and use commercially reasonable efforts
to file their respective quarterly reports on the same day;
provided , however , that the foregoing requirement
shall not apply to the first quarterly reporting period of Verigy
following the IPO if Verigy is not required by the Exchange Act to
file its Form 10-Q for such period within forty-five
(45) days of the end of such quarter.
(v)
Annual Financial Statements
. As soon as practicable and within
Agilent’s standard financial reporting timeline, and in any
event no later than ten (10) Business Days prior to the date
on which Agilent has notified Verigy that Agilent intends to file
its Form 10-K or other document containing annual financial
statements with the SEC, Verigy will deliver to Agilent
(A) drafts of the consolidated financial statements of the
Verigy Group (and notes thereto) for such year, setting forth in
each case in comparative form the consolidated figures (and notes
thereto) for the previous fiscal year and all in reasonable detail
and prepared in accordance with Regulation S-X and GAAP and
(B) a discussion and analysis by management of the Verigy
Group’s financial condition and results of operations for
such year, including, without limitation, an explanation of any
material period-to-period change and any off-balance sheet
transactions, all in reasonable detail and prepared in accordance
with Item 303(a) of Regulation S-K. The information set forth
in (A) and (B) above is referred to in this Agreement as
the “ Annual Financial Statements .” Verigy will
deliver to Agilent all revisions to such drafts as soon as any such
revisions are prepared or made. No later than three
(3) Business Days prior to the date on which Agilent has
notified Verigy that Agilent intends to file the Agilent annual
financial statements with the SEC, Verigy will deliver to Agilent
the final form of the Verigy Annual Financial Statements and
certifications thereof by the principal executive and financial
officers of Verigy in substantially the forms required under SEC
rules for periodic reports and in form and substance satisfactory
to Agilent; provided , however , that Verigy may
continue to revise such Annual Financial Statements prior to the
filing thereof in order to make corrections and changes which
corrections and changes will be delivered by Verigy to Agilent as
soon as practicable, and in any event within eight (8) hours
thereafter; provided , further , that Agilent and
Verigy financial Representatives will actively consult with each
other regarding any changes (whether or not substantive) which
Verigy may consider making to its Annual Financial Statements and
related disclosures during the three (3) Business Days
immediately prior to any anticipated filing with the SEC, to the
extent such changes would have an effect upon Agilent’s
financial statements or related disclosures. In addition to the
foregoing, no Annual Financial Statement or any other document
which refers, or contains information not previously publicly
disclosed with respect, to the ownership of Verigy by Agilent, the
separation of Verigy from Agilent or the Distribution will be filed
with the SEC or otherwise made public by any Verigy Group member
without the prior consent of Agilent, which will not be
unreasonably withheld. In any event, Verigy will use its
commercially reasonable efforts to deliver to Agilent, no later
than three (3) days prior to the date that on which Agilent
has notified Verigy that Agilent intends to file the Agilent annual
financial statements with the SEC, the final form of the Annual
Financial Statements accompanied by an opinion thereon by
Verigy’s independent certified public accountants. Agilent
and Verigy will cooperate with each other and use commercially
reasonable efforts to file their respective annual reports on the
same day.
9
(vi)
Affiliate Financial Statements
. Verigy will use its commercially
reasonable efforts to deliver to Agilent all Quarterly and Annual
Financial Statements of each Verigy Affiliate which is itself
required to file financial statements with the SEC or otherwise
make such financial statements publicly available, with such
financial statements to be provided in the same manner and detail
and on the same time schedule as those financial statements of
Verigy required to be delivered to Agilent pursuant to this
Section 6.1.
(vii)
Conformance with Agilent Financial
Presentation . All information provided
by any Verigy Group member to Agilent or filed with the SEC
pursuant to Section 6.1(a)(iii) through
(vi) inclusive will be consistent in terms of format and
detail and otherwise with Agilent’s policies with respect to
the application of GAAP and practices with respect to the provision
of such financial information by such Verigy Group member to
Agilent, with such changes therein as may be requested by Agilent
from time to time consistent with changes in such accounting
principles and practices.
(viii)
Verigy Reports Generally
. Each Verigy Group member that files
information with the SEC will deliver to Agilent:
(A) substantially final drafts, as soon as the same are
prepared, of (x) all reports, notices and proxy and
information statements to be sent or made available by such Verigy
Group member to its respective security holders, (y) all
regular, periodic and other reports to be filed or furnished under
Sections 13, 14 and 15 of the Exchange Act (including Reports on
Forms 10-K, 10-Q and 8-K and Annual Reports to Shareholders), and
(z) all registration statements and prospectuses to be filed
by such Verigy Group member with the SEC or any securities exchange
pursuant to the listed company manual (or similar requirements) of
such exchange (collectively, the documents identified in clauses
(x), (y) and (z) are referred to in this Agreement as
“ Verigy Public Documents ”), and (B) as
soon as practicable, but in no event later than four
(4) Business Days (other than with respect to 8-Ks) prior to
the earliest of the dates the same are printed, sent or filed,
current drafts of all such Verigy Public Documents and, with
respect to 8-Ks, as soon as practicable, but in no event later than
two (2) Business Days prior to the earliest of the dates the
same are printed, sent or filed in the case of planned 8-Ks and as
soon as practicable, but in no event less than two (2) hours
in the case of unplanned 8-Ks; provided , however ,
that Verigy may continue to revise such Verigy Public Documents
prior to the filing thereof in order to make corrections and
changes which corrections and changes will be delivered by Verigy
to Agilent as soon as practicable, and in any event (other than in
connection with unplanned 8-Ks) within eight (8) hours
thereafter; provided , further , that Agilent and
Verigy financial Representatives will actively consult with each
other regarding any changes which Verigy may consider making to any
of its Verigy Public Documents and related disclosures prior to any
anticipated filing with the SEC, to the extent that such changes
would have an effect upon Agilent’s financial statements or
related disclosures. In addition to the foregoing, no Verigy Public
Document or any other document which refers, or contains
information not previously publicly disclosed with respect, to the
ownership of Verigy by Agilent, the separation of Verigy from
Agilent or the Distribution will be filed with the SEC or otherwise
made public by any Verigy Group member without the prior consent of
Agilent, which will not be unreasonably withheld.
(ix)
Budgets and Financial Projections
. Verigy will, as promptly as practicable
and within Agilent’s standard budgeting timeline, deliver to
Agilent copies of all annual and other budgets and financial
projections (consistent in terms of format and detail and otherwise
required by Agilent) relating to Verigy on a consolidated basis and
will provide Agilent an opportunity to meet with management of
Verigy to discuss such budgets and projections.
(x) Other
Information . With reasonable
promptness, Verigy will deliver to Agilent such additional
financial and other information and data with respect to the Verigy
Group and their business, properties, financial positions, results
of operations and prospects as from time to time may be reasonably
requested by Agilent.
10
(xi)
Press Releases and Similar
Information . Verigy and Agilent will
consult with each other as to the timing of their annual and
quarterly earnings releases and any interim financial guidance for
a current or future period and will give each other the opportunity
to review the information therein relating to the Verigy Group and
to comment thereon. Agilent and Verigy will make reasonable efforts
to issue their respective annual and quarterly earnings releases at
approximately the same time on the same date. No later than
twenty-four (24) hours prior to the time and date that a party
intends to publish its regular annual or quarterly earnings release
or any financial guidance for a current or future period, such
party will deliver to the other party copies of substantially final
drafts (or relevant portions thereof) of all press releases and
other statements to be made available by any member of that
party’s Group to employees of any member of that
party’s Group or to the public to the extent (and only to the
extent) such releases and statements concern matters that could be
reasonably likely to have a material financial impact on the
earnings, results of operations, financial condition or prospects
of any Verigy Group member. In addition, prior to the issuance of
any such press release or public statement that meets the criteria
set forth in the preceding two sentences, the issuing party will
consult with the other party regarding any changes (other than
typographical or other similar minor changes) to such substantially
final drafts. Immediately following the issuance thereof, the
issuing party will deliver to the other party copies of final
drafts of all press releases and other public
statements.
(xii)
Cooperation on Agilent Filings
. Verigy will cooperate fully, and will use
its best efforts to cause Verigy’s Auditors to cooperate
fully, with Agilent to the extent requested by Agilent in the
preparation of Agilent’s public earnings or other press
releases, Quarterly Reports on Form 10-Q, Annual Reports to
Shareholders, Annual Reports on Form 10-K, any Current Reports
on Form 8-K and any other proxy, information and registration
statements, reports, notices, prospectuses and any other filings
made by Agilent with the SEC, any national securities exchange or
otherwise made publicly available (collectively, the “
Agilent Public Filings ”). Verigy agrees to provide to
Agilent all information that Agilent reasonably requests in
connection with any Agilent Public Filings or that, in the
reasonable judgment of Agilent’s legal department, is
required to be disclosed or incorporated by reference therein under
any law, rule or regulation. Verigy will use its best efforts to
provide such information in a timely manner on the dates requested
by Agilent (which may be earlier than the dates on which Verigy
otherwise would be required hereunder to have such information
available) to enable Agilent to prepare, print and release all
Agilent Public Filings on such dates as Agilent will determine but
in no event later than as required by applicable law. Verigy will
use its commercially reasonable efforts to cause Verigy’s
Auditors to consent to any reference to them as experts in any
Agilent Public Filings required under any law, rule or regulation.
If and to the extent requested by Agilent, Verigy will diligently
and promptly review all drafts of such Agilent Public Filings and
prepare in a diligent and timely fashion any portion of such
Agilent Public Filing pertaining to Verigy. Prior to any printing
or public release of any Agilent Public Filing, an appropriate
executive officer of Verigy will, if requested by Agilent, certify
that (1) the information relating to any Verigy Group member
or the Business in such Agilent Public Filing does not contain any
untrue statement of a material fact or omit to state a material
fact necessary to make the statements made, in light of the
circumstances under which they were made, not misleading and
(2) the financial information relating to any Verigy Group
member or the Business in such Agilent Public Filing fairly
presents, in all material respects, the financial condition,
results of operations and cash flows of such Verigy Group member or
the Business, as the case may be, for the periods presented in the
release or the Agilent Public Filing. Unless required by law, rule
or regulation, Verigy will not publicly release any financial or
other information which conflicts with the information with respect
to any Verigy Group member or the Business that is included in any
Agilent Public Filing without Agilent’s prior written
consent, which will not be unreasonably withheld. Prior to the
release or filing thereof, Agilent will provide Verigy with a draft
of any portion of an Agilent Public Filing containing information
relating to the Verigy Group and will give Verigy an opportunity to
review such information and comment thereon; provided that Agilent
will determine in its sole and absolute discretion the final form
and content of all Agilent Public Filings.
11
(b)
Auditors and Audits; Annual Statements
and Accounting . Verigy agrees that, for
so long as Agilent is required to consolidate Verigy’s
results of operations and financial position or to account for its
investment in Verigy under the equity method of accounting (in
accordance with GAAP):
(i) Audit
Timing . Verigy will use its
commercially reasonable efforts to enable its independent certified
public accountants (“ Verigy’s Auditors ”)
to complete their audit such that they will date their opinion on
the Annual Financial Statements on the same date that
Agilent’s independent certified public accountants (“
Agilent’s Auditors ”) date their opinion on
Agilent’s audited annual financial statements (the “
Agilent Annual Statements ”), and to enable Agilent to
meet its timetable for the printing, filing and public
dissemination of the Agilent Annual Statements, all in accordance
with Section 6.1(a) hereof and as required by applicable
law.
(ii)
Information Needed by Agilent
. Verigy will use its best efforts to
provide to Agilent on a timely basis all information that Agilent
reasonably requires to meet its schedule for the preparation,
printing, filing, and public dissemination of the Agilent Annual
Statements and Agilent’s quarterly financial statements in
accordance with Section 6.1(a) hereof and as required by
applicable law. Without limiting the generality of the foregoing,
Verigy will use its best efforts to provide all required financial
information with respect to the Verigy Group to Verigy’s
Auditors in a sufficient and reasonable time and in sufficient
detail to permit Verigy’s Auditors to take all steps and
perform all reviews necessary to provide sufficient assistance to
Agilent’s Auditors with respect to information to be included
or contained in the Agilent Annual Statements and Agilent’s
quarterly financial statements.
(iii)
Access to Verigy Auditors
. Verigy will authorize Verigy’s
Auditors to make available to Agilent’s Auditors both the
personnel who performed, or are performing, the annual audit of
Verigy and work papers related to the annual audit of Verigy, in
all cases within a reasonable time prior to Verigy’s
Auditors’ opinion date, so that Agilent’s Auditors are
able to perform the procedures they consider necessary to take
responsibility for the work of Verigy’s Auditors as it
relates to Agilent’s Auditors’ report on
Agilent’s statements, all within sufficient time to enable
Agilent to meet its timetable for the printing, filing and public
dissemination of the Agilent Annual Statements.
(iv)
Access to Records
. At Agilent’s request, Verigy will
provide Agilent’s internal auditors with access to the Verigy
Group’s books and records so that Agilent may conduct
reasonable audits relating to the financial statements provided by
Verigy under this Agreement as well as to the internal accounting
controls and operations of the Verigy Group.
(v)
Notice of Changes
. Subject to Section 6.1(a)(vii),
Verigy will give Agilent as much prior notice as reasonably
practicable of any proposed determination of, or any significant
changes in, Verigy’s accounting estimates or accounting
principles. Verigy will consult with Agilent and, if requested by
Agilent, Verigy will consult with Agilent’s Auditors with
respect thereto. Verigy will not make any such determination or
changes without Agilent’s prior written consent, which will
not be unreasonably withheld, if such a determination or a change
would be sufficiently material to be required to be disclosed in
Verigy’s or Agilent’s financial statements as filed
with the SEC or otherwise publicly disclosed therein.
(vi)
Accounting Changes Requested by
Agilent . Notwithstanding
clause (vi) above, Verigy will make any changes in its
accounting estimates or accounting principles that are requested by
Agilent in order for Verigy’s accounting practices and
principles to be consistent with those of Agilent.
(vii)
Special Reports of Deficiencies or
Violations . Verigy will report in
reasonable detail to Agilent the following events or circumstances
promptly after any executive officer of Verigy or any member of the
Verigy Board of Directors becomes aware of such matter:
(A) all actual or potential significant deficiencies and
material weaknesses in the design or operation of
internal
12
control over financial reporting
which are reasonably likely to adversely affect Verigy’s
ability to record, process, summarize and report financial
information; (B) any fraud, whether or not material, that
involves management or other employees who have a significant role
in Verigy’s internal control over financial reporting;
(C) any illegal act within the meaning of Section 10A(b)
and (f) of the Exchange Act; and (D) any report of a
material violation of law that an attorney representing any Verigy
Group member has formally made to any officers or directors of
Verigy pursuant to the SEC’s attorney conduct rules (17
C.F.R. Part 205).
6.2.
Other Covenants.
In addition to the other covenants
contained in this Agreement and the Transaction Documents, Verigy
hereby covenants and agrees that, for so long as Agilent
beneficially owns at least fifty percent (50%) of the total voting
power of all classes of then outstanding share capital of Verigy
entitled to vote generally in the election of directors (“
Verigy Voting Shares ”):
(a) Verigy will
not, without the prior written consent of Agilent (which Agilent
may w